Delivery Order SPE2DB24D2109-SPE2DB24FHWDH

Award Date 9/4/24
Potential Completion Date 9/25/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price contract. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,624.62 firm fixed-price delivery order is for 4565454468 TASIGNA 150 MG CAPSULE 28S, a prescription medication. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen holds large Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, worth up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,007.90 firm fixed-price delivery order is for the supply of 4567752226 TASIGNA 150 MG CAPSULE 28S. The contract has an ultimate completion date of April 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price of $11,638.02 and a completion date of March 25, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply TASIGNA 150 MG CAPSULE 28S. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $6,007.90 and a period of performance through April 22, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $11,249.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG capsules, a specialty medication, with a completion date of November 26, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,819.01, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a $5,624.62 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide TASIGNA 150 MG CAPSULE 28S, with a completion date of February 15, 2024. This award is part of a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as Amerisourcebergen's primary contract to deliver pharmaceuticals and medical...
This federal contract award, valued at $11,638.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product, and has a completion date of March 3, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB24FHWDH
    Delivery Order

This federal contract award, valued at $5,624.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide TASIGNA 150 MG CAPSULE 28S to support federal healthcare programs. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, has an ultimate completion date of September 25, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for delivering a wide range of medical commodities to federal agencies. This contract award is not associated with a set-aside program.

Generated 12/4/24, 9:57 AM